Skip to main content
GLGL Biopharm

GL Biopharm

Rooted in cutting-edge bioscience, safeguarding the future of human health

Explore Our BusinessPartner With Us

About GL Biopharm

GL Biopharm builds on research strength in microbiology, pharmaceutical sciences and food nutrition, focusing on three core tracks: innovative drug R&D, next-generation vaccine technology, and medicine-food homology functional food development. We connect the full chain from basic research to industrialisation, turning cutting-edge science into health products for the public.

03
Core Business Units
04
R&D Technology Platforms
06
Pipeline Programs
04
Core Team Members

Three Core Business Units

A multi-track R&D system covering pharmaceuticals, vaccines and health food

🧪

Drug Development

Focus on innovative drugs for anti infection and inflammatory metabolism, layout lead compound screening, pharmacological evaluation, preclinical research, and promote the pipeline of innovative candidate drugs.

Learn More→
💉

Vaccine development

Conduct research on a new vaccine technology platform, focusing on the design of new antigens, optimization of formulation processes, and exploration of safer and more effective vaccine candidate solutions.

Learn More→
🌿

Development of functional food and health products

Deeply cultivating the direction of medicinal food homology and microbial nutrition, developing dietary supplements and functional foods, and developing compliant products for the mainland and Hong Kong/Macau markets.

Learn More→

Our Core Advantages

01

Research Foundation

University-anchored, multidisciplinary team spanning microbiology, pharmacy and food nutrition

02

Full Pipeline Capability

End-to-end capability from target discovery and formulation development to scale-up and industrialisation

03

Compliance-Driven

Well-versed in the regulatory frameworks for medicines and functional food across mainland China and Hong Kong

04

Open Collaboration

Multi-modal partnerships with research institutes, industrial capital and manufacturers

Latest Updates

Hong Kong Biopharmaceutical expands its functional food pipeline and deepens the layout of the health industry in Guangdong, Hong Kong, and MacauCompany

Hong Kong Biopharmaceutical expands its functional food pipeline and deepens the layout of the health industry in Guangdong, Hong Kong, and Macau

The company announced the expansion of its functional food and health product pipeline, further deepening the layout of the health industry in the Guangdong Hong Kong Macao Greater Bay Area.

Participate in international biomedical academic conferences and share cutting-edge research on new drugs and vaccinesEvents

Participate in international biomedical academic conferences and share cutting-edge research on new drugs and vaccines

The company's R&D team was invited to attend the International Biomedical Academic Conference to share the latest developments in anti infective new drugs and new vaccine platforms.

Collaborate with research institutions on industry university research projectsCompany

Collaborate with research institutions on industry university research projects

The company has signed industry university research cooperation agreements with multiple research institutions to jointly promote the conversion of candidate drugs and functional foods.

All News →

Partner with us to create new opportunities in the health industry

Start a Partnership